NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Alpenglow Biosciences

Alpenglow Biosciences

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.alpenglowbiosciences.com/

Last Round

VC Round

Jan 8, 2026

Total Funding Raised

$12.92M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Alpenglow Biosciences is a life sciences company that provides a 3D spatial biology platform using AI-enabled imaging technology to accelerate drug development and improve clinical diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Imaging, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

spatial biology3D pathologydigital pathologylight-sheet microscopy3D imagingtissue imagingAI pathologycomputational pathologydrug discoveryprecision medicinetumor heterogeneitybiotech equipmenthistology servicessmart microscopy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alpenglow Biosciences Comparables

Compare Alpenglow Biosciences with similar companies based on industry and business-model similarity.

Alpenglow Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Alpenglow Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 8, 2026
Convertible DebtDec 31, 2025
VC RoundAug 15, 2024
GrantAug 15, 2024
GrantAug 1, 2023
Grant
Apr 11, 2022

Key People

Founding team and executive leadership

Nicholas Reder

Chief Executive Officer

Executive Team

Alpenglow Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 25, 2026

    Finalist for Innovation of the Year at the 2026 GeekWire Awards.

  • Mar 25, 2026

    Named a finalist for the Innovation of the Year award.

Alpenglow Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alpenglow Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alpenglow Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range31
Year Founded2018
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.